检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈晨[1] 胡晓康 王恺婧 黄周青[1] CHEN Chen;HU Xiaokang;WANG Kaijing;HUANG Zhouqing(Cardiovascular Department,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325015,China;Department of Ultrasound,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325015,China)
机构地区:[1]温州医科大学附属第一医院心血管内科,浙江温州325015 [2]温州医科大学附属第一医院超声影像科,浙江温州325015
出 处:《温州医科大学学报》2019年第12期910-913,共4页Journal of Wenzhou Medical University
摘 要:目的:探讨CA-125在阵发性和持续性心房颤动(简称房颤)患者中的表达水平及其意义。方法:回顾性分析2017年6月至2018年6月在温州医科大学附属第一医院住院的642例房颤患者临床资料。将入组房颤患者根据阵发/持续房颤分为2组,比较临床资料(年龄、性别、BMI、房颤病程、左房内径、射血分数、BNP、肝肾功能、CHA2DS2-VASc评分、CA-125等),应用多因素logistic回归分析持续性房颤的危险因素。结果:与阵发性房颤患者相比,持续性房颤患者的CA-125水平更高(P<0.001)。Logistic回归分析显示CA-125是持续性房颤的独立危险因素(P<0.05)。结论:CA-125可能是持续性房颤的预测指标。Objective:To investigate the significance of CA-125 in patients with paroxysmal and persistent atrial fibrillation(AF).Methods:A retrospective study was made of 642 patients admitted to the First Affiliated Hospital of Wenzhou Medical University(China)from June 2017 to June 2018.All subjects enrolled were divided into two groups according to episode/persistent AF and they were compared in paroxysmal AF and persistent AF.Their clinical data(age,gender,BMI,duration of AF,left atrial diameter,ejection fraction,BNP,liver and kidney function,CHA2DS2-VASc score,CA-125,etc.)were analyzed to identify the risk factors of persistent AF by multivariate regression analysis.Results:Statistical regression results showed that patients with persistent AF had higher levels of CA-125(P<0.001)compared with patients with paroxysmal AF.Logistic regression analyses showed that CA-125 levels appeared to be unaffected by age,LAD,ejection fraction,sex and so on.Conclusion:Patients with persistent AF have higher CA-125 level.
分 类 号:R541.7[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3